Novavax shares fell 11.2% during Wednesday's session. Vaccine stocks are volatile after the first US bird flu death and a CDC ...

The stock's fall snapped a five-day winning streak.

Moderna (MRNA) was on track to see a weekly gain of 10% as of Wednesday. Shares of the vaccine maker rose 11.7% the prior day following the first reported bird flu death in the US. The stock reversed ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Vaccine stocks received a major and sudden boost on January 7, 2025. Here's why these companies are experiencing tailwinds in ...

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Shortly after President-elect Donald J. Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human ...

Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.

The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus.

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

Unusual total active option classes on open include: Getty Images ( GETY ), Nkarta ( NKTX ), Truist Financial ( TFC ), Pac Bio ( PACB ), Enovix ( ENVX ), Novavax ( NVAX ), Nokia ( NOK ), Cerence ( ...

Investing.com -- Shares of Moderna (NASDAQ: MRNA) and CureVac (NASDAQ:CVAC) are climbing in Tuesday's premarket trading as seasonal flu cases in the United States show a marked increase. Moderna's ...